Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Guangdong Kanghua Healthcare Co., Ltd. Class H ( (HK:3689) ) has shared an announcement.
Guangdong Kanghua Healthcare Group Co., Ltd. announced a significant turnaround in its financial performance for the first half of 2025, expecting a profit of RMB32.0 million to RMB33.0 million compared to a loss of RMB24.7 million in the same period of 2024. This improvement is primarily due to the disposal of a 55% equity interest in Kangxin Hospital, which resulted in a gain of approximately RMB19.5 million. The de-consolidation of Kangxin Hospital’s financial results, which had been loss-making, contributed positively to the Group’s overall financial health.
The most recent analyst rating on (HK:3689) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on Guangdong Kanghua Healthcare Co., Ltd. Class H stock, see the HK:3689 Stock Forecast page.
More about Guangdong Kanghua Healthcare Co., Ltd. Class H
Guangdong Kanghua Healthcare Group Co., Ltd. is a healthcare company based in China, focusing on providing medical services through its network of hospitals and healthcare facilities.
Average Trading Volume: 115,464
Technical Sentiment Signal: Sell
Current Market Cap: HK$638.7M
Find detailed analytics on 3689 stock on TipRanks’ Stock Analysis page.